Mkts

Nuvation Bio Inc.

NYSE: NUVB
$4.16-0.03 (-0.72%)
As of Nov 6, 4:00 PM ET

Key statistics

Day range
3.984.33
52-week range
3.989.75
Today
Open4.21
Previous close4.16
Volume—
Valuation
Market cap1.46B
P/E ratio—
EPS (TTM)-0.44
Income & risk
Dividend / yield—
Beta1.79
Avg volume5.65M
Discussion

NUVB News

Stories mentioning NUVB from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue83,22841,86513,1204,8333,0845,711727.001,435
Cost of Goods Sold3,3492,5762,0944,2161,5151,347
Gross Profit9,7712,257990.001,495(788.00)88.00
Operating Expenses
Research & Development35,04734,29728,84627,36224,60129,29927,73129,247
Sales General & Admin38,30940,32637,35938,48435,39326,13819,58216,156
Total Operating Expenses79,34781,82766,20565,84662,08862,51547,313470,473
Operating Income (Loss)3,881(34,037)(56,434)(63,589)(59,004)(53,942)(48,101)(470,385)
Interest Income
Interest Expense5,121132.00
Other Expense
Pretax Income5,397(36,592)(55,792)(59,007)(53,236)(49,445)(41,210)(462,492)
Tax Provision0.000.000.000.000.000.000.000.00
Net Income (Loss)5,397(36,592)(55,792)(59,007)(53,236)(49,445)(41,210)(462,492)
Earnings Per Share (Basic)0.02(106.99)(0.16)(0.17)(0.16)(183.81)(0.15)(1.89)
Earnings Per Share (Diluted)0.01(106.99)(0.16)(0.17)(0.16)(183.81)(0.15)(1.89)
Weighted Average Shares Outstanding (Basic)347.00342.00342.00341.00339.00269.00274.00245.00
Weighted Average Shares Outstanding (Diluted)378.00342.00342.00341.00339.00269.00274.00245.00

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About NUVB

Nuvation Bio Inc. (NYSE: NUVB) is a stock listed on the New York Stock Exchange under the ticker symbol NUVB. It last traded at $4.16 (Nov 6, 2026, 4:00 PM ET), down 0.7% on the day. That gives Nuvation Bio a market capitalisation of $1.5B.

Over the past 52 weeks NUVB has traded between $3.98 and $9.75.

Revenue for the quarter ended Mar 31, 2026 was $83.2M; net income $5.4M. Revenue was up 2599% from $3.1M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$83.2M$5.4M6.5%
Dec 31, 2025$41.9M-$36.6M-87.4%
Sep 30, 2025$13.1M-$55.8M-425.2%
Jun 30, 2025$4.8M-$59.0M-1220.9%

From Nuvation Bio’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…